We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$735M
AUM Growth
+$76.2M
Cap. Flow
+$18.4M
Cap. Flow %
2.5%
Top 10 Hldgs %
31.56%
Holding
2,736
New
105
Increased
1,030
Reduced
598
Closed
101

Sector Composition

Rank Sector Weight
1 Technology 13.99%
2 Financials 7.71%
3 Industrials 6.04%
4 Consumer Discretionary 5.68%
5 Healthcare 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBRG icon
1801
DigitalBridge
DBRG
$2.95B
$13.3K ﹤0.01%
1,137
DHT icon
1802
DHT Holdings
DHT
$3.02B
$13.3K ﹤0.01%
1,109
-17
-2% -$197
TCBX icon
1803
Third Coast Bancshares
TCBX
$738M
$13.3K ﹤0.01%
349
BMI icon
1804
Badger Meter
BMI
$4.03B
$13.2K ﹤0.01%
74
-40
-35% -$7.87K
AVXL icon
1805
Anavex Life Sciences
AVXL
$310M
$13.2K ﹤0.01%
1,484
NEO icon
1806
NeoGenomics
NEO
$2.13B
$13.2K ﹤0.01%
1,708
+1,009
+144% +$7.07K
OMCL icon
1807
Omnicell
OMCL
$1.68B
$13.2K ﹤0.01%
433
+6
+1% +$184
UPWK icon
1808
Upwork
UPWK
$1.19B
$13.2K ﹤0.01%
710
-510
-42% -$7.6K
PAYX icon
1809
Paychex
PAYX
$42.7B
$13.2K ﹤0.01%
104
-1,068
-91% -$148K
IIPR icon
1810
Innovative Industrial Properties
IIPR
$1.72B
$13.2K ﹤0.01%
246
+225
+1,071% +$12.2K
MTDR icon
1811
Matador Resources
MTDR
$6.09B
$13.2K ﹤0.01%
293
+247
+537% +$12.1K
WAFD icon
1812
WaFd
WAFD
$2.75B
$13.1K ﹤0.01%
434
BCPC
1813
Balchem Corp
BCPC
$5.72B
$13.1K ﹤0.01%
87
-177
-67% -$27.9K
UTHR icon
1814
United Therapeutics
UTHR
$23.1B
$13K ﹤0.01%
31
SNDX icon
1815
Syndax Pharmaceuticals
SNDX
$1.82B
$13K ﹤0.01%
844
+22
+3% +$288
OBK icon
1816
Origin Bancorp
OBK
$1.66B
$13K ﹤0.01%
376
KRRO icon
1817
Korro Bio
KRRO
$195M
$13K ﹤0.01%
271
-11
-4% -$244
APLS
1818
DELISTED
Apellis Pharmaceuticals
APLS
$13K ﹤0.01%
573
-31
-5% -$723
RARE icon
1819
Ultragenyx Pharmaceutical
RARE
$2.55B
$13K ﹤0.01%
431
+127
+42% +$3.81K
HL icon
1820
Hecla Mining
HL
$11.3B
$12.9K ﹤0.01%
1,069
+86
+9% +$691
MQ icon
1821
Marqeta
MQ
$1.66B
$12.9K ﹤0.01%
610
SOFI icon
1822
SoFi Technologies
SOFI
$23.7B
$12.8K ﹤0.01%
486
ZBH icon
1823
Zimmer Biomet
ZBH
$18.4B
$12.8K ﹤0.01%
130
+98
+306% +$9.71K
ATKR icon
1824
Atkore
ATKR
$3.16B
$12.8K ﹤0.01%
204
-1,074
-84% -$70K
ONTF
1825
DELISTED
ON24
ONTF
$12.8K ﹤0.01%
+2,235
New +$12K

Similar funds

Versant Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Versant Capital Management held 2,736 positions worth $735M, up 12% from $659M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Versant Capital Management's Q3 2025 filing shows 105 new, 1,030 increased, 598 reduced and 101 closed positions. Its largest new stake was WisdomTree International Hedged Quality Dividend Growth Fund: 7,816 shares worth $360K. The largest sale was Avantis International Equity ETF, an estimated $3.24M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

  • Versant Capital Management's largest Q3 2025 buy was WisdomTree International Hedged Quality Dividend Growth Fund: 7,816 shares worth $360K.
  • Versant Capital Management added most to FlexShares Global Upstream Natural Resources Index Fund in Q3 2025, an estimated $2.08M increase.
  • Versant Capital Management's biggest Q3 2025 reduction was Avantis International Equity ETF, cutting an estimated $3.24M.
  • Versant Capital Management fully exited Amedisys in Q3 2025, selling an estimated $310K.
  • Versant Capital Management's ten largest holdings make up 32% of its $735M portfolio in Q3 2025.
  • Versant Capital Management opened 105 new positions and closed 101 in Q3 2025.
  • Versant Capital Management's portfolio value rose 12% quarter-over-quarter to $735M.

Based on Versant Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.